Morphine and outcomes in acute decompensated heart failure: An ADHERE analysis

Emergency Medicine Journal

Volumn 25, Issue 4, 2008, Pages 205-209

  Peacock, W F ^a   Hollander, J E ^b   Diercks, D B ^c   Lopatin, M ^d   Fonarow, G ^e   Emerman, C L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SCIOS INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIURETIC AGENT; GLYCERYL TRINITRATE; HEMOGLOBIN; INOTROPIC AGENT; MORPHINE; NESIRITIDE; NITROPRUSSIDE SODIUM; TROPONIN; VASODILATOR AGENT;

ACUTE HEART FAILURE; ADVERSE OUTCOME; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART RATE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CARDIOPULMONARY RESUSCITATION; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; MORPHINE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 41849095637     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2007.050419     Document Type: Article

References (16)

1. Forrester JE, Waters DD. Hospital treatment of congestive heart failure. Management according to hemodynamic profile. Am J Med 1978;65:173-80.
2. Chamberlain DA, Williams JH. Immediate care of cardiac emergencies. Anesthesia 1976;31:758-63.
3. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384-416.
4. Fonarow GC. Pharmacologic therapies for acutely decompensated heart failure. Rev Cardiovasc Med 2002;3(Suppl 4):S18-27.
5. Grossmann M, Abiose A, Tangphao O, et al. Morphine-induced venodilation in humans. Clin Pharmacol Ther 1996;60:554-60.
6. Vismara L, Leaman DM, Zelis R. The effects of mophine on venous tone in patients with acute pulmonary edema. Circulation 1976; 54:335-7.
7. Johnson MJ, McDonagh TA, Harkness A, et al. Morphine for the relief of breathlessness in patients with chronic heart failure: a pilot study. Eur J Heart Fail 2002;4:753-6.
8. Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005;46:57-64.
9. Fonarow GC, Adams KF Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensatad heart failure: classification and regression tree analysis. ADHERE Scientific Advisory Committee, Study Group, and Investigators. JAMA 2005; 293:572-80.
10. Ramirez A, Abelman WH. Current concepts: cardiac decompensation. N Engl J Med 1974;290:499-501.
11. VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002;287:1531-40.
12. Sacchetti A, Ramoska E, Moakes ME, et al. Effect of ED management on ICU use in acute pulmonary edema. Am J Emerg Med 1999;17:571-4.
13. Timmis AD, Rothman MT, Henderson MA, et al. Haemodynamic effects of intravenous morphine in patients with acute myocardial infarction complicated by severe left ventricular failure. BMJ 1980;980-2.
14. Weurz RC, Meador SA. Effects of prehospital medications on mortality and length of stay in congestive heart failure. Ann Emerg Med 1992;21:669-74.
15. Hoffman JR, Reynolds S. Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. Chest 1987;92:586-93.
16. Canto JG, Kiefe CI, Williams OD, et al. Comparison of outcomes research with clinical trials using preexisting data. Am J Cardiol 1999;84:923-7.